Evidence map›Paper›PMID 34191699›Full record

ReviewCurrent neuropharmacology2022

SARS-Cov-2 Damage on the Nervous System and Mental Health.

Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Mikhail Arisov, Julia Fedotova, Lucia Gozzo, Filippo Drago, Weihong Lu, Alexey Sarapultsev, Vadim Tseilikman and 1 more

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Mohamed Said BoulkraneInternational Research Centre \'Biotechnologies of the Third Millennium\', ITMO University, Saint-Petersburg, Russia.
Victoria IlinaInternational Research Centre \'Biotechnologies of the Third Millennium\', ITMO University, Saint-Petersburg, Russia.
Roman MelchakovInternational Research Centre \'Biotechnologies of the Third Millennium\', ITMO University, Saint-Petersburg, Russia.
Mikhail ArisovAll-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plants, a branch of the Federal State Budget Scientific Institution "Federal Scientific Centre VIEV", Moscow, Russia.
Julia Fedotovanternational Research Centre \'Biotechnologies of the Third Millennium\', ITMO University, Saint-Petersburg, Russia.
Lucia GozzoDepartment of Biomedical and Biotechnological Sciences, Biological Tower, School of Medicine, University of Catania, Catania, Italy.
Filippo DragoDepartment of Biomedical and Biotechnological Sciences, Biological Tower, School of Medicine, University of Catania, Catania, Italy.
Weihong LuInstitute of Extreme Environment Nutrition and Protection, Harbin Institute of Technology, Harbin, China.
Alexey SarapultsevSchool of Medical Biology, South Ural State University, 76 Lenin prospect, Chelaybinsk, Russia.
Vadim TseilikmanSchool of Medical Biology, South Ural State University, 76 Lenin prospect, Chelaybinsk, Russia.
Denis BaranenkoInternational Research Centre \'Biotechnologies of the Third Millennium\', ITMO University, Saint-Petersburg, Russia.
ITMO University · RUSouth Ural State University · RUUniversity of Catania · ITAll-Russian Scientific Research Institute of Fundamental and Applied Parasitology of Animals and Plants named after K.I. Skryabin · RUHarbin Institute of Technology · CN

Funding

RFBR/NSFC 20-515-55003
6 · The paper itself

Abstract

The World Health Organization declared the pandemic situation caused by SARSCoV- 2 (Severe Acute Respiratory Syndrome Coronavirus-2) in March 2020, but the detailed pathophysiological mechanisms of Coronavirus disease 2019 (COVID-19) are not yet completely understood. Therefore, to date, few therapeutic options are available for patients with mildmoderate or serious disease. In addition to systemic and respiratory symptoms, several reports have documented various neurological symptoms and impairments of mental health. The current review aims to provide the available evidence about the effects of SARS-CoV-2 infection on mental health. The present data suggest that SARS-CoV-2 produces a wide range of impairments and disorders of the brain. However, a limited number of studies investigated the neuroinvasive potential of SARS-CoV-2. Although the main features and outcomes of COVID-19 are linked to severe acute respiratory illness, the possible damages on the brain should be considered, too.

Indexed as

COVID-19Nervous System DiseasesHumansMental HealthSARS-CoV-2brain disordersCOVID-19mental healthneuroinvasive potentialneurological diseasesSARS-CoV-2

Identifiers

PMID34191699
PMCPMC9413788
OpenAlexW3174973285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.